The analysis showed that BC patients with high expression of TBC1D9 had better survival outcome for distance metastasis free survival (DMFS) and post-progression survival (PPS), with a p-value of 0.0014 and 0.0088 respectively. The gene discussed is TBC1D9; the disease is breast cancer.